Takeda stops development of prostate cancer drug TAK-700
TAK-700 (orteronel) is an inhibitor of testosterone biosynthesis (a sterol 17,20-lyase inhibitor). Results in phase III tests were disappointing. Takeda news release, June 19, 2014
J-TEC announces success for autologous skin replacement in Epidermolysis bullosa
Clinical trials for autologous skin tissue treatment of Epidermolysis bullosa, an inherited skin disease, were successfully completed. J-TEC news release, June 19, 2014
Kyowa Hakko Kirin starts clinical trials on Alzheimer-directed peptide antibody
The clinical phase I tests, using an anti-Aß antibody developed by Kyowa Hakko Kirin subsidiary Oncotherapy, will be done in Belgium. They cover Alzheimer’s disease in a prodromal phase Kyowa Hakko Kirin news release, June 19, 2104